The US Federal Trade Commission (FTC) is suing Edwards Lifesciences to stop it from acquiring JenaValve, citing anticompetitive concerns.

Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based CRC screening test in the US.

Medical Device Network sat down with Dexcom's outgoing CEO Kevin Sayer to learn more about how the company will maintain its market position and drive innovation in the CGM space in the future.

A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of the ...

HeartFlow is set to be listed on the Nasdaq under the symbol ‘HTFL’. Seeking a valuation of $1.46bn, the California-based company aims to raise $300m by offering 16.7 million shares priced between $17 ...

MedTech Europe has reiterated the importance of tariff-free trade for medical technologies following the US decision to impose reciprocal tariffs of 15% on most goods from Europe.

Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA).

The FDA has granted a second 510(k) clearance to expand the use of Respiree’s RS001 cardio-respiratory wearable to home use.

Artificial intelligence (AI) is having a profound influence on the healthcare space across multiple domains. Notably, however, the technology is often more of a support tool than a wholesale ...

Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.